Renaissance Technologies LLC Sells 84,700 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Renaissance Technologies LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 91.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,630 shares of the medical equipment provider's stock after selling 84,700 shares during the period. Renaissance Technologies LLC's holdings in Intuitive Surgical were worth $3,983,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Atala Financial Inc acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $28,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Finally, Summit Securities Group LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 35,454 shares of company stock worth $18,564,027. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Up 1.3 %

NASDAQ ISRG traded up $6.46 on Friday, reaching $514.59. The stock had a trading volume of 2,015,889 shares, compared to its average volume of 1,614,265. Intuitive Surgical, Inc. has a 1 year low of $367.39 and a 1 year high of $616.00. The business has a 50 day moving average price of $513.65 and a 200 day moving average price of $532.19. The company has a market capitalization of $183.29 billion, a price-to-earnings ratio of 80.28, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company posted $1.50 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have commented on ISRG. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Royal Bank of Canada cut their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Evercore ISI dropped their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.